[1] Fung J, Lee CK, Chan M, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census. Liver Int, 2015, 35: 542-549
[2] 黄锦平,危静,陈兆军,等.彩色多普勒超声诊断男性青年非酒精性脂肪性肝病相关因素分析.浙江临床医学,2015, 17: 1039-1040
[3] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).现代医药卫生,2011, 27: 641-644
[4] 中华人民工和国卫生部医政司.全国临床检验操作规程.3版.南京:东南大学出版社,2006:1024-1027
[5] 张大鹍,陈敏,刘阳,等. ARFI与APRI指数对非酒精性脂肪性肝病肝纤维化的诊断价值. 中国临床医学影像杂志,2013,24:178-181.
[6] Ferraioli G, Tinelli C, Lissandrin R, er al. Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals: a pilot study. Eur J Gastroentterol Hepatol, 2015, 27: 305-312
[7] 朱璐,张堃,尹天雷,等.超声评价复方丹金丸治疗非酒精性脂肪性肝病疗效及其与中医证候疗效相关性研究.中国中西医结合影像学杂志,2015,13: 37-39, 43.
[8] Bhatt SP, Misra A, Nigam P, et al. Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study. PloS One, 2015, 10: e0142260.
[9] Crespol G, Ferna ndez Varo G, Marino Z, et al. ARFI, Fibroscan, ELF, and their combinations in the assessment of liver fibrosis:a prospective study. Hepatol, 2012, 57: 281-287.
[10] 朱远航,朱冬林,陈江玲,等. 常用血清学指标对肝纤维化程度的预测值.放射免疫学杂志,2013,26:392-395.
[11] Kanth VV, Sasikala M, Rao PN, et al. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study. Worol J Hepatol, 2014, 6: 435-442.
[12] 宛伟娜,刘晓破.老年非酒精性脂肪肝患者超声影像与血脂紊乱的相关性分析.中国老年保健医学,2010,8: 17-28.
[13] Hatziagelaki E, Herder C, Tsiavou A, et al. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD). PloS One, 2015, 10: e0124935. |
